“…Studies have shown that multiple factors are involved in the pathogenesis of depression, such as low functioning of the monoamine nervous system (Borroto-Escuela et al, 2021), inflammation (Beurel et al, 2020;Novakovic et al, 2023), nerve damage and regeneration disorders (Tartt et al, 2022;Thompson, 2023), dysfunction of the HPA axis (Herzog et al, 2023), oxidative stress (Bhatt et al, 2020), and genetic and psychosocial factors (Zhao et al, 2022;Ross et al, 2023), etc. The pathogenesis fits right in with the broad pharmacologic effects of Ber as mentioned above, and an increasing number of in vitro and in vivo experiments have focused on the validation of the antidepressant effects of Ber (Zhu et al, 2017;LU et al, 2021;YU et al, 2021;Wang et al, 2022b).…”